RNS Number : 5348M Dunelm Group plc 16 July 2026 16 July 2026Dunelm Group plcQ4 and full year trading updateContinued sales growth and cost delivery; full year profit in line with expectationsDunelm Group plc ("Dunelm" or "the Group"), the UK's leading homewares retailer, updates on trading for…
RNS Number : 5337M MTI Wireless Edge Limited 16 July 2026 16 July 2026MTI Wireless Edge Ltd("MTI" or the "Group")Multiple Contract Wins Worth c. US$4mStrong period of demand with orders received across all three divisions with deliveries expected within the next nine monthsMTI Wireless Edge Ltd…
Q2 2026 saw solid growth with 2% end-user service revenue and 4% EBITDAaL increases, driven by strong performance in Sweden Business and the Baltics. Financial leverage improved to 1.7x, and guidance for 2026 remains unchanged.Original document: Tele2 AB Class A [TEL2_A] Slides Release — Jul. 16 20…
Record Q2 orders and revenues were driven by strong demand in electrification and automation, with robust margin expansion and cash flow. Strategic acquisitions, including Rotork, and investments in manufacturing support future growth, while operational execution and disciplined capital management…
Q2 2026 delivered a strong turnaround with EBIT and net profit both positive year-over-year, driven by operational improvements, cost reductions, and strategic restructuring. Cash flow and capital efficiency improved, while risks remain from market volatility, supply chains, and unresolved warranty…
NAV rose to NOK 106.1 billion in H1 2026, driven by Nscale and Cognite transactions, with a 53.3% total shareholder return. The Cognite sale will boost liquidity and reduce debt, while Aker BP and Nscale remain key assets amid volatile markets.Original document: Aker ASA Class A [AKER] Interim repo…
Q2 2026 saw revenue and EBITDA declines due to market pressure in the Nordics and Bangladesh, VAT provisions, and tough comparables. Strategic acquisitions and transformation initiatives are underway, with a revised 2026 outlook reflecting flat to slightly negative EBITDA growth and continued focus…
Operating revenues and cash flow improved year-over-year, but profitability was impacted by higher costs, a NOK 337 million impairment on Alginor, and non-recurring expenses. Segment results were mixed, with Fine Chemicals and BioMaterials up, but BioSolutions down. Equity ratio remains strong at 5…
Q2 2026 saw a return to profit, driven by strong unrealized value gains in financial assets and increased operational activity, including the start of major development projects. The company remains financially robust, with a solid equity ratio and reduced debt, and is well-positioned for further g…
Pipeline programs OX640 and Izipry advanced toward pivotal milestones, with key trials and regulatory submissions on track for late 2026 and early 2027. Financials reflect lower revenues, increased legal and restructuring costs, and a need for additional financing to support ongoing development and…
Revenue grew 6.2% year-over-year to EUR 241.0 million in H1 2026, with B2B and international sales driving growth and profitability improving in Q2. Operational efficiency, cost discipline, and a strong financial position supported ongoing dividends and share buybacks.Original document: Verkkokaupp…
Order intake and net sales grew strongly in Q2 2026, with profitability rebounding as gross margin rose to 28.1% and operating profit turned positive. Strategic wins, including a major Canadian contract, and cost-saving measures position the company for continued growth.Original document: Pricer AB…
Net sales grew 2.6% year-over-year, driven by higher volumes in key segments, while profitability remained resilient despite cost inflation and geopolitical volatility. Strategic actions included a SEK 3bn share buyback and a strategic review of Consumer Tissue.Original document: Essity AB Class A…
Turnover and profitability surged in H1 2026, driven by acquisitions and organic growth, with strong performance across all regions and customer diversification reducing risk. The outlook for H2 is positive, supported by integration of MB Elettronica and new customer programs.Original document: Sca…
ABB Ltd / Key word(s): Quarter ResultsQ2 2026 results16-Jul-2026 / 07:05 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.ZURICH, SWITZERLAND, JULY 16, 2026Record-high orders, strong operational execution and value…
ABB Ltd: Q2 2026 resultsAd hoc Announcement pursuant to Art. 53 Listing Rules of SIX Swiss ExchangeZurich, Switzerland, July 16, 2026Q2 2026 resultsRecord-high orders, strong operational execution and value creation through M&A“Q2 reflects the strength of ABB’s performance and position at the core…
NAV stood at NOK 106 billion after a NOK 2.2 billion dividend, with a major Cognite sale boosting liquidity and reducing net debt. Listed investments declined due to energy sector headwinds, while Nscale and Aker BP delivered strong operational results.Original document: Aker ASA Class A [AKER] Sli…
Q2 2026 saw a 3% revenue increase and robust cash flow, but EBITDA declined 1% year-over-year due to higher costs and a NOK 337 million impairment. Segment results were mixed, with Fine Chemicals outperforming, while BioSolutions faced margin pressure.Original document: Borregaard ASA [BRG] Slides…
Revenue grew 13% to €152.0 million, with recurring revenue up 17% and net profit up 35%. All key markets contributed to growth, especially Livestock and Healthcare, while investments in technology and cloud solutions continued. Net debt turned negative and solvency improved.Original document: Nedap…
During the first half of 2026, Aker’s NAV increased by close to NOK 40 billion after dividends paid, to NOK 106 billion, reflecting a combination of value realization and strong performance across Aker’s portfolio. In the quarter, Aker signed a landmark agreement to sell Cognite to Schneider Electr…
